February 28, 2017 / 7:45 AM / 7 months ago

BRIEF-Herantis Pharma H2 loss shrinks to EUR 1.8 million

Feb 28 (Reuters) - Herantis Pharma Oyj:

* H2 loss 1.8 million euros ($1.9 million) versus loss 2.5 million euros year ago

* Does not expect essential revenues in 2017

* Expects to be cash positive at end of year 2017 Source text for Eikon: Further company coverage: ($1 = 0.9447 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below